Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment

被引：0
|
作者：
Clémence Chevalier
Julie Dubourg
Sébastien Bolze
Pascale Fouqueray
机构：
[1] Poxel SA,
来源：
Clinical Pharmacokinetics | 2021年 / 60卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 490
页数：5
相关论文
共 50 条
  • [31] Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment
    Angelika Weil
    Paul Martin
    Robert Smith
    Stuart Oliver
    Peter Langmuir
    Jessica Read
    Karl-Heinz Molz
    [J]. Clinical Pharmacokinetics, 2010, 49 : 607 - 618
  • [32] Pharmacokinetics and tolerability of semaglutide in subjects with hepatic impairment
    Arold, G.
    Kupcova, V.
    Jensen, L.
    Kvist, T.
    Pettersson, J.
    Hjerpsted, J.
    [J]. DIABETOLOGIA, 2017, 60 : S380 - S381
  • [33] Pharmacokinetics of sunitinib malate in subjects with hepatic impairment
    Bello, Carlo L.
    Garrett, May
    Sherman, Laurie
    Smeraglia, John
    Ryan, Bob
    Toh, Melvin
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 699 - 707
  • [34] Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment
    S. G. Simonson
    P. D. Martin
    P. Mitchell
    D. W. Schneck
    K. C. Lasseter
    M. J. Warwick
    [J]. European Journal of Clinical Pharmacology, 2003, 58 : 669 - 675
  • [35] PHARMACOKINETICS AND SAFETY OF NITAZOXANIDE IN SUBJECTS WITH HEPATIC IMPAIRMENT
    Harisseh, Rania
    Finnegan, Beth
    Thomas, Stephane
    Legry, Vanessa
    Hum, Dean
    Marbury, Thomas C.
    Perry, Robert G.
    Wyatt, David J.
    Addy, Carol
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1391 - S1391
  • [36] Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment
    Simonson, SG
    Martin, PD
    Mitchell, P
    Schneck, DW
    Lasseter, KC
    Warwick, MJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (10) : 669 - 675
  • [37] Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment
    Weil, Angelika
    Martin, Paul
    Smith, Robert
    Oliver, Stuart
    Langmuir, Peter
    Read, Jessica
    Molz, Karl-Heinz
    [J]. CLINICAL PHARMACOKINETICS, 2010, 49 (09) : 607 - 618
  • [38] Pharmacokinetics of sunitinib malate in subjects with hepatic impairment
    Carlo L. Bello
    May Garrett
    Laurie Sherman
    John Smeraglia
    Bob Ryan
    Melvin Toh
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 66 : 699 - 707
  • [39] Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment
    John Marcinak
    Majid Vakilynejad
    Akifumi Kogame
    Yoshihiko Tagawa
    [J]. Drugs in R&D, 2018, 18 : 109 - 118
  • [40] Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
    Akifumi Kurata
    Takafumi Yoshida
    Megumi Inoue
    Tomoko Ishizuka
    Takafumi Nakatsu
    Takako Shimizu
    Manabu Kato
    Yasuhiro Nishikawa
    Hitoshi Ishizuka
    [J]. Advances in Therapy, 2020, 37 : 253 - 264
12345